Elsevier Introduces Cardiac Electrophysiology Clinics
Philadelphia, 27 April 2010 - Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces a new addition to the Clinics of North America series – Cardiac Electrophysiology Clinics.
Under the expert guidance of Consulting Editors Dr. Ranjan Thakur and Dr. Andrea Natale, each issue is devoted to a single topic that covers the most significant concerns in this field. According to Dr. Thakur, the goal of Cardiac Electrophysiology Clinics is “to provide comprehensive reviews of contemporary issues of interest to clinicians. Electrophysiologists as well as other cardiologists and physicians caring for patients with arrhythmias will find these issues helpful in clinical decision making.”
Dr. Thakur is Professor of Medicine and Program Director of the Cardiac Electrophysiology Fellowship at Michigan State University and Director of the Arrhythmia Service at the Thoracic and Cardiovascular Institute, Sparrow Health System, in Lansing, Michigan. Dr. Natale is Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin Texas.
The initial issues of this quarterly publication feature the following topics:
- Sudden Cardiac Death: Despite emergency medical response systems, long-term survival from out-of-hospital cardiac arrest remains poor in most US cities. This issue covers the full spectrum of issues related to sudden cardiac death, including the epidemiology of sudden cardiac death, advances in CPR, the implantable cardiac defibrillator (ICD), and ventricular tachycardia ablation.
- Epicardial Interventions in Electrophysiology: Epicardial ablation is a relatively new technique that is less invasive than traditional surgical ablation. It shows promise in certain patient populations. This issue of Cardiac Electrophysiology Clinics is one of the first collections of articles on this cutting edge technique.
- Advances in Arrhythmia Analyses: A Case-Based Approach: This issue is a valuable tool to help electrophysiologists interpret complex ECGs so they can better understand arrhythmia mechanisms. Organized by cases, this issue illustrates many of the classic electrocardiographic findings and phenomena that every electrophysiologist should know.
- Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Arrhythmogenic right ventricular dysplasia is an inherited heart muscle disorder that may cause abnormal electrical heart rhythms and weakening of the pumping action of the heart, resulting in sudden death. The electrocardiograph (EKG) is used to diagnose the disease, so it is important for cardiac electrophysiologists to be familiar with the disease and to be able to recognize it on the EKG.
- Advances in Antiarrhythmic Drug Therapy: Cardiac electrophysiologists have many options for treating arrhythmias, including catheter ablation and implantable cardiac defibrillators. Antiarrhythmic agents, which are pharmaceutical agents used to suppress fast rhythms of the heart (cardiac arrhythmias), represent another treatment option. This issue summarizes the most current thinking on the role of pharmaceuticals in relation to other types of treatment, helping electrophysiologists to determine the best method for managing their patients.
A personal subscription to Cardiac Electrophysiology Clinics includes full text online access to each issue as it publishes on Theclinics.com. institutions through MD Consult, Journals Consult and ScienceDirect. Visit booth #316 at Heart Rhythm 2010, May 13-15th, to learn more or visit cardiacep.theclinics.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com